FindTrial
Sign In

A long-term extension study of AG-1749 in patients on concomitant long-term non-steroidal antiinflammatory drug (NSAIDs) use

A long-term extension study of AG-1749 in patients on concomitant long-term non-steroidal antiinflammatory drug (NSAIDs) use

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220831
Enrollment
Unknown
Registered
2009-08-26
Start date
2009-08-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of ulcer associated with NSAIDs

Interventions

investigational material(s) Generic name etc : AG-1749 INN of investigational material : Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational material

Sponsors

Takeda Pharmaceutical Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who have finished the preceding confirmatory anti-ulcer efficacy study 2.Patients who are on oral NSAIDs therapy at the time of consent and who require continued long-term NSAIDs use even after the start of study treatment in this study

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026